HSPG2 and hepatocellular carcinoma: To confirm our clinical observations and to analyze mechanisms underlying the sensitivity of HCC cells to LEN in vitro, we first performed a cell viability assay using previously established PLC/PRF5 and SOR-resistant PLC/PRF5-R2 cell lines [20].